Abstract
Rationale
Previous experiments in our laboratory have shown that d-penicillamine (DP) (acetaldehyde sequestering agent) is able to block the increase in ethanol consumption observed after a period of imposed deprivation (the so-called alcohol deprivation effect (ADE)), using a non-operant paradigm in Wistar rats.
Objectives
This study is aimed at investigating the robustness and reproducibility of our previous data using an operant paradigm, which is considered to be a valid and reliable model of human drug consumption, and the ADE, probably the most often used measure of ethanol relapse-drinking behaviour in rats.
Methods
Male Wistar rats with a limited (30-min sessions), intermittent and extended background of ethanol operant self-administration were used. In order to evaluate the efficacy of several DP doses (6.25, 12.5 and 25 mg/kg i.p.) in preventing alcohol relapse, we set up a protocol based on the ADE. In a separate experiment, the effect of DP on spontaneous motor activity of rats was also tested.
Results
A significant ADE was observed in animals treated with saline. DP treatment blocked the increase in ethanol responses following the imposed abstinence period. The higher dose suppressed the ADE and provoked a significant reduction in ethanol consumption with respect to the baseline conditions. Basal motor activity was not altered after DP treatment.
Conclusion
Our positive results with DP, using two different paradigms that evaluate relapse of ethanol drinking, will help to increase the positive predictive value of pre-clinical experiments and offer a solid base to inspire human studies with DP.
Similar content being viewed by others
References
Alen F, Gomez R, Gonzalez-Cuevas G, Navarro M, Lopez-Moreno JA (2009) Nicotine causes opposite effects on alcohol intake: evidence in an animal experimental model of abstinence and relapse from alcohol. Nicotine Tob Res 11:1304–1311. doi:10.1093/ntr/ntp139
Belin-Rauscent A, Fouyssac M, Bonci A, Belin D (2015) How preclinical models evolved to resemble the diagnostic criteria of drug addiction. Biol Psychiatr. doi: S0006-3223(15)00047-5
Bell RL, Sable HJ, Colombo G, Hyytia P, Rodd ZA, Lumeng L (2012) Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity. Pharmacol Biochem Behav 103:119–155. doi:10.1016/j.pbb.2012.07.007
Bossert JM, Marchant NJ, Calu DJ, Shaham Y (2013) The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) 229:453–476. doi:10.1007/s00213-013-3120-y
Ciccocioppo R (2013) Genetically selected alcohol preferring rats to model human alcoholism. Curr Top Behav Neurosci 13:251–269. doi:10.1007/7854_2012_199
Correa M, Salamone JD, Segovia KN, Pardo M, Longoni R, Spina L, Peana AT, Vinci S, Acquas E (2012) Piecing together the puzzle of acetaldehyde as a neuroactive agent. Neurosci Biobehav Rev 36:404–430. doi:10.1016/j.neubiorev.2011.07.009
Dhaher R, Hauser SR, Getachew B, Bell RL, McBride WJ, McKinzie DL, Rodd ZA (2010) The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J Addict Med 4:153–159. doi:10.1097/ADM.0b013e3181bd893f
Enrico P, Sirca D, Mereu M, Peana AT, Lintas A, Golosio A, Diana M (2009) Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Drug Alcohol Depend 100:265–271. doi:10.1016/j.drugalcdep.2008.10.010
Font L, Aragon CM, Miquel M (2006) Voluntary ethanol consumption decreases after the inactivation of central acetaldehyde by d-penicillamine. Behav Brain Res 171:78–86. doi:10.1016/j.bbr.2006.03.020
Font L, Miquel M, Aragon CMG (2005) Prevention of ethanol-induced behavioral stimulation by d-penicillamine: a sequestration agent for acetaldehyde. Alcohol Clin Exp Res 29:1156–1164
Heyser CJ, Moc K, Koob GF (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28:1463–1471. doi:10.1038/sj.npp.1300175
Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125–133. doi: S0893-133X(97)00130-9
Holter SM, Landgraf R, Zieglgansberger W, Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21:862–868. doi: 00000374-199708000-00014
Kera Y, Kiriyama T, Komura S (1985) Conjugation of acetaldehyde with cysteinylglycine, the first metabolite in glutathione breakdown by gamma-glutamyltranspeptidase. Agents Actions 17:48–52
Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML, Falk DE, Moss H, Huebner R, Noronha A (2012) Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17:513–527. doi:10.1111/j.1369-1600.2012.00454.x
Lopez-Moreno JA, Gonzalez-Cuevas G, Rodriguez de Fonseca F, Navarro M (2004) Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J Neurosci 24:8245–8252. doi:10.1523/JNEUROSCI.2179-04.2004
Marti-Prats L, Sanchez-Catalan MJ, Hipolito L, Orrico A, Zornoza T, Polache A, Granero L (2010) Systemic administration of d-penicillamine prevents the locomotor activation after intra-VTA ethanol administration in rats. Neurosci Lett 483:143–147. doi:10.1016/j.neulet.2010.07.081
Melis M, Diana M, Enrico P, Marinelli M, Brodie MS (2009) Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress. Alcohol 43:531–539. doi:10.1016/j.alcohol.2009.05.004
Mobley A, Linder SK, Braeuer R, Ellis LM, Zwelling L (2013) A survey on data reproducibility in cancer research provides insights into our limited ability to translate findings from the laboratory to the clinic. PLoS One 8:e63221. doi:10.1371/journal.pone.0063221
Muggironi G, Fois GR, Diana M (2013) Ethanol-derived acetaldehyde: pleasure and pain of alcohol mechanism of action. Front Behav Neurosci 17:87. doi:10.3389/fnbeh.2013.00087
Nagasawa HT, Elberling JA, DeMaster EG (1980) Structural requirements for the sequestration of metabolically generated acetaldehyde. J Med Chem 23:140–143
Nature Editorial (2013) Reducing our irreproducibility. Nature 496:398
Orrico A, Marti-Prats L, Cano-Cebrian MJ, Granero L, Polache A, Zornoza T (2014a) Improved effect of the combination naltrexone/d-penicillamine in the prevention of alcohol relapse-like drinking in rats. J Psychopharmacol 28:76–81. doi:10.1177/0269881113515063
Orrico A, Marti-Prats L, Cano-Cebrian MJ, Polache A, Zornoza T, Granero L (2014b) Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in rats. Biopharm Drug Dispos 35:284–295. doi:10.1002/bdd.1896
Orrico A, Hipolito L, Sanchez-Catalan MJ, Marti-Prats L, Zornoza T, Granero L, Polache A (2013) Efficacy of d-penicillamine, a sequestering acetaldehyde agent, in the prevention of alcohol relapse-like drinking in rats. Psychopharmacology (Berl) 228:563–575. doi:10.1007/s00213-013-3065-1
Peana AT, Muggironi G, Calvisi G, Enrico P, Mereu M, Nieddu M, Boatto G, Diana M (2010) l-Cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats. Pharmacol Biochem Behav 94:431–437. doi:10.1016/j.pbb.2009.10.005
Peana AT, Enrico P, Assaretti AR, Pulighe E, Muggironi G, Nieddu M, Piga A, Lintas A, Diana M (2008) Key role of ethanol-derived acetaldehyde in the motivational properties induced by intragastric ethanol: a conditioned place preference study in the rat. Alcohol Clin Exp Res 32:249–258. doi:10.1111/j.1530-0277.2007.00574.x
Reilly MT, Noronha A, Warren K (2014) Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism. Handb Clin Neurol 125:15–29. doi:10.1016/B978-0-444-62619-6.00002-1
Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD, McBride WJ (2006) The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav Brain Res 171:207–215. doi: S0166-4328(06)00189-6
Rodd ZA, Bell RL, Sable HJ, Murphy JM, McBride WJ (2004) Recent advances in animal models of alcohol craving and relapse. Pharmacol Biochem Behav 79:439–450. doi: S0091-3057(04)00275-8.
Rosner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M (2010) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 8(12):CD001867. doi: 10.1002/14651858.CD001867.pub2
Sanchez-Catalan MJ, Hipolito L, Zornoza T, Polache A, Granero L (2009) Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors. Psychopharmacology (Berl) 204:641–653
Schroeder JP, Overstreet DH, Hodge CW (2005) The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) 179:262–270. doi:10.1007/s00213-005-2175-9
Sirca D, Enrico P, Mereu M, Peana AT, Diana M (2011) l-Cysteine prevents ethanol-induced stimulation of mesolimbic dopamine transmission. Alcohol Clin Exp Res. doi:10.1111/j.1530-0277.2010.01416.x
Spanagel R, Vengeliene V (2013) New pharmacological treatment strategies for relapse prevention. Curr Top Behav Neurosci 13:583–609. doi:10.1007/7854_2012_205
Steckler T (2015) Preclinical data reproducibility for R&D–the challenge for neuroscience. Psychopharmacology (Berl) 232:317–320. doi:10.1007/s00213-014-3836-3
Vengeliene V, Bilbao A, Spanagel R (2014) The alcohol deprivation effect model for studying relapse behavior: a comparison between rats and mice. Alcohol 48:313–320. doi:10.1016/j.alcohol.2014.03.002
Walker BM, Koob GF (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33(3):643–652. doi: 1301438
Acknowledgments
This research was supported by the European Foundation for Alcohol Research and the Fondo de Investigación Sanitaria (Red de Trastornos Adictivos, FEDER, 12/0028/0015). LM-P is a recipient of an ‘Atracció de Talent’ grant from Universitat de València.
Conflict of interest
All authors report having no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martí-Prats, L., Zornoza, T., López-Moreno, J.A. et al. Acetaldehyde sequestration by d-penicillamine prevents ethanol relapse-like drinking in rats: evidence from an operant self-administration paradigm. Psychopharmacology 232, 3597–3606 (2015). https://doi.org/10.1007/s00213-015-4011-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-015-4011-1